SynthesisFrontiers in endocrinology2022

Comparative Cardiovascular Outcomes of SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Network Meta-Analysis of Randomized Controlled Trials.

Yu Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.